-+ 0.00%
-+ 0.00%
-+ 0.00%

Alzheimer's disease pathology research company AlzPath and Quanterix expand a strategic licensing agreement to advance the next generation of Alzheimer's disease biomarkers research.

Zhitongcaijing·10/07/2026 12:41:23
Listen to the news
Alzheimer's disease pathology research company AlzPath and Quanterix expand a strategic licensing agreement to advance the next generation of Alzheimer's disease biomarkers research.